Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can online therapy help scleroderma patients manage daily life?

NCT ID NCT07661836

Symptom relief Sponsor: Universidad de Zaragoza Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a personalized online occupational therapy program is feasible and helpful for adults with scleroderma. Twenty-four participants in Spain will either receive eight online therapy sessions over four weeks plus usual care, or usual care alone. The study focuses on whether people can complete the program and if it improves daily functioning and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized online occupational therapy sessions
What this could lead to
If it works, this could provide a convenient, home-based way to help people with scleroderma manage daily tasks and improve their quality of life.
What could go wrong
This is a very small pilot study (24 people) testing feasibility, not effectiveness. The intervention is short (4 weeks) and may not show lasting benefits or work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

May 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older with scleroderma from the previous project cohort and meeting the general eligibility criteria of the initial study. * Current residence in Spain. * Sufficient Spanish language ability to provide informed consent, participate in the intervention, and complete study assessments. * Ability to understand the study information and provide informed consent, with support if needed. * Access to the internet and to a device compatible with Google Meet and Hefora. * Availability to participate in eight online sessions of approximately 60 minutes, twice weekly over four weeks. * Not currently participating in a specific occupational therapy program or another intervention that could substantially influence functioning, activities of daily living, quality of life, or occupational balance. * Provision of informed consent and completion of the baseline assessment. Exclusion Criteria: * Clinical condition or severe comorbidity preventing safe participation. * Current residence outside Spain. * Inability to provide informed consent or complete the baseline assessment. * Concurrent participation in a specific occupational therapy program or another intensive, potentially interfering rehabilitation or therapeutic education intervention. * Withdrawal of interest before the effective start of the intervention or inability to participate during the planned study dates.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Scleroderma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diffuse scleroderma scleroderma systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Scleroderma Scleroderma (limited and diffuse) Systemic sclerosis (SSC)

Contacts and locations

Locations

  • Universidad de Zaragoza

    Zaragoza, Zaragoza / Aragón, 50009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.